These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 19551725)

  • 1. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
    Shuai L; Wang S; Zhang L; Fu B; Zhou X
    Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
    Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
    Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
    Bridewell DJ; Finlay GJ; Baguley BC
    Anticancer Drug Des; 2001 Dec; 16(6):317-24. PubMed ID: 12375884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5,7-Disubstituted analogues of the mixed topoisomerase I/II poison N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA): DNA binding and patterns of cytotoxicity.
    Spicer JA; Finlay GJ; Baguley BC; Velea L; Graves DE; Denny WA
    Anticancer Drug Des; 1999 Feb; 14(1):37-45. PubMed ID: 10363026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.
    Abdel-Aziz M; Matsuda K; Otsuka M; Uyeda M; Okawara T; Suzuki K
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1669-72. PubMed ID: 15026047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA interaction and dual topoisomerase I and II inhibition properties of the anti-tumor drug prodigiosin.
    Montaner B; Castillo-Avila W; Martinell M; Ollinger R; Aymami J; Giralt E; Pérez-Tomás R
    Toxicol Sci; 2005 Jun; 85(2):870-9. PubMed ID: 15788728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition.
    Krishnan P; Bastow KF
    Anticancer Drug Des; 2000 Aug; 15(4):255-64. PubMed ID: 11200501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes.
    Kobayashi Y; Yamashita Y; Fujii N; Takaboshi K; Kawakami T; Kawamura M; Mizukami T; Nakano H
    Planta Med; 1995 Oct; 61(5):414-8. PubMed ID: 7480201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
    Lo YC; Ko TP; Su WC; Su TL; Wang AH
    J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-topoisomerase inhibitors.
    D'Incalci M
    Curr Opin Oncol; 1993 Nov; 5(6):1023-8. PubMed ID: 8305535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding topoisomerase I and II in terms of QSAR.
    Verma RP
    Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.
    Riou JF; Helissey P; Grondard L; Giorgi-Renault S
    Mol Pharmacol; 1991 Nov; 40(5):699-706. PubMed ID: 1658605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New carbocyclic lexitropsins with dinitromustard as N-terminal fragment. Inhibition of topoisomerases.
    Markowska A; Bielawska A; Bielawski K; Midura-Nowaczek K
    Acta Pol Pharm; 2003; 60(2):119-21. PubMed ID: 13678319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
    Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
    Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
    Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
    Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, GC selective DNA binding and topoisomerase II inhibition activities of ruthenium(II) polypyridyl complex containing 11-aminopteridino[6,7-f][1,10]phenanthrolin-13(12H)-one.
    Gao F; Chao H; Zhou F; Chen X; Wei YF; Ji LN
    J Inorg Biochem; 2008; 102(5-6):1050-9. PubMed ID: 18295337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships.
    Suzuki K; Okawara T; Higashijima T; Yokomizo K; Mizushima T; Otsuka M
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2065-8. PubMed ID: 15808469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA binding properties of 9-substituted harmine derivatives.
    Cao R; Peng W; Chen H; Ma Y; Liu X; Hou X; Guan H; Xu A
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1557-63. PubMed ID: 16288723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)].
    Vashisht Gopal YN; Konuru N; Kondapi AK
    Arch Biochem Biophys; 2002 May; 401(1):53-62. PubMed ID: 12054487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.